A Novel First-in-class 3D Printing Technology for Advanced Manufacturing of Complex Vaccine Formulations against Influenza and Emerging Infectious Diseases

$498,119R01FY2023FDFDA

University Of Mississippi, University MS

Investigators

Mohammed Maniruzzamancontact

Linked publications & trials

Paper 39349578 Paper 37149110 Paper 37075953 Paper 35654388

View original record on NIH RePORTER →

A Novel First-in-class 3D Printing Technology for Advanced Manufacturing of Complex Vaccine Formulations against Influenza and Emerging Infectious Diseases · GrantIndex